Dr. Mohammed Marwan Abuzahra, MD

Dr. Abuzahra practices at Sinai Hospital of Baltimore in Baltimore, Maryland, part of LifeBridge Health.

Dr. Abuzahra's NPI, 1053366013, was assigned on May 24, 2006. Dr. Abuzahra graduated from American University of Beirut Faculty of Medicine in 2002. Dr. Abuzahra's Texas license number on file is M2523.

Dr. Abuzahra's primary practice is Sinai Hospital of Baltimore, at 2401 West Belvedere Avenue, Baltimore, MD 21215 in Baltimore City. The practice phone is (410) 601-9000.

Dr. Abuzahra's primary practice is Sinai Hospital of Baltimore in Baltimore, Maryland, part of LifeBridge Health. Dr. Abuzahra is also affiliated with University of Maryland Medical Center. The medical group on file is Sinai Rehab Pain Medicine Associates. Dmand AI also links Dr. Abuzahra to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abuzahra practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Abuzahra's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Abuzahra is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Abuzahra's licenses on file in 2 states: Texas and Maryland.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart blockage, heart failure and heart valve disorders among the conditions Dr. Abuzahra treats.

CMS data shows 4,397 Medicare services from Dr. Abuzahra across 19 procedure codes in 2024, for 1,903 Medicare patients. Medicare paid $214,644 for them.

CMS counts 1,903 Medicare patients who saw Dr. Abuzahra in 2024. The largest group is 75 to 84, with 668 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abuzahra's median patient age at 65, with 54% women.

In 2024, Dr. Abuzahra wrote 2,496 Medicare Part D claims for 347 patients. 84% of them were for generic drugs. CMS names the drug for 2,295 of them, across 33 drugs with 11 or more claims each, at $453,689 in total drug cost. In 2023, CMS named 1,970 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Abuzahra for performance year 2024, reported individually.

Dmand AI links 3 papers to Dr. Abuzahra, published from 2008 to 2022. Dr. Abuzahra's most frequent co-authors are Angel Eduardo Caldera, MD, Danish Mahmud Jilani, MD and Manu Pillai, MD.

CMS Open Payments shows 579 general payments to Dr. Abuzahra from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Daiichi Sankyo Inc. paid the most, $6,607.

Dmand AI lists 2 awards for Dr. Abuzahra, most recently Alpha Omega Alpha in 2002.

Dr. Abuzahra graduated from American University of Beirut Faculty of Medicine in 2002. Dr. Abuzahra is a member of ACC.

Dr. Abuzahra is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.